权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Targeting Super-Enhancers Suppresses Cancer Stemness and Invasion of HNSCC

靶向超级增强剂抑制癌症干细胞和 HNSCC 的侵袭

基本信息

批准号：
10618847
负责人：
CUN-YU WANG
金额：
$ 39.75万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-08-01 至 2025-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10618847
关键词：
Acetylation Amino Acid Motifs BMI1 gene Binding Biological Assay Bromodomain Bromodomains and extra-terminal domain inhibitor Cell Separation Cells Cervical lymph node group ChIP-seq Chemoresistance Colorectal Cancer Combination Drug Therapy Common Neoplasm Complex Cyclin-Dependent Kinases Development Enhancers Epigenetic Process Exhibits Family member Gene Expression Genes Genetic Transcription Genomic Segment Genomics Growth Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Head and neck structure Histone Acetylation Histone H3 Histone H4 Human Impairment Individual Invaded Lysine Malignant Neoplasms Mediator Metastatic Neoplasm to Lymph Nodes Michigan Molecular Mutation Neck Neck Cancer Neoplasm Metastasis Neurofibrillary Tangles Nitroquinolines Oncogenes Oncogenic Oral cavity Oropharyngeal Oxides Patients Play Prognosis Protein Family Proteins RNA Polymerase II Reader Relapse Resistance Resistance development Role Subgroup Survival Rate Testing Tissues Transcript Transcription Coactivator Transcription Elongation Transcription Initiation Transcriptional Activation Transcriptional Regulation Tumor Cell Invasion Tumor Promotion Universities cancer cell cancer stem cell cancer therapy cofactor effective therapy genetic approach improved in vivo inhibitor malignant breast neoplasm mouse model novel novel strategies novel therapeutic intervention novel therapeutics patient derived xenograft model prevent protein degradation recruit self-renewal stemness therapeutic target transcription factor transcriptome sequencing treatment strategy tumor tumor growth tumorigenic

项目摘要

The long-term objectives of this application are to understand how super-enhancers (SEs) control the invasive growth and metastasis of head and neck squamous cell carcinoma (HNSCC) and to develop novel therapeutics for HNSCC. HNSCC is highly invasive and resistant to cancer therapy and frequently metastasizes to cervical lymph node, and patients with HNSCC have poor prognosis compared to other cancers such as breast and colorectal cancers. Therefore, novel effective therapies need to be developed for HNSCC patients. SEs are a genomic region that consists of multiple enhancers which are collectively bound by a set of transcription factors and epigenetic readers to drive transcription of genes associated with cell identity. Bromodomain-containing protein 4 (BRD4) is one of the four bromodomain and extra-terminal motif (BET) protein family members. In SEs, BRD4 functions as an epigenetic reader that recognizes and interacts with acetylated lysine residues on histone H3 and H4. Upon binding to the acetylated histones, BRD4 recruits the Mediator complex, the cyclin-dependent kinase 7 (CDK7) complex, and other factors to facilitate transcription initiation and elongation. Growing evidence suggests that SEs preferentially regulated the transcription of key oncogenes in various cancers which can be selectively inhibited by BET inhibitors (BETi). To explore whether SEs are a therapeutic target for HNSCC, we performed preliminary studies to characterize SEs in HNSCC, and discovered that SEs selectively controlled the transcription of a set of oncogenic genes associated with cancer stemness and invasion in addition to some common tumor-promoting genes. Using the newly-established mouse model of HNSCC that allows us to trace cancer stem cells (CSCs) in vivo, we found that disruption of SEs by BETi could potently eliminate CSCs and inhibit HNSCC invasive growth in vivo. We also showed that the new BET degrader (BETd) potently inhibited the expression of cancer stemness and pro-invasive genes by inducing BET family protein degradation. Based on these exciting preliminary studies, in this application, we hypothesize that SEs control the expression of cancer stemness and pro-invasive genes, and targeting SEs by BETd might help to eliminate CSCs and block tumor cell invasion, thereby improving anti-tumor efficacy and preventing lymph node metastasis of HNSCC. To test our hypothesis, we propose the following three specific aims: 1) Determine whether disruption of SEs suppresses tumor invasive growth and metastasis and effectively eliminates CSCs in a mouse model of HNSCC; 2) Determine whether the disruption of SEs inhibits the self-renewal, tumorigenic potentials and metastasis of CSCs isolated from human HNSCC; and 3) Determine how SEs are assembled in HNSCC and explore the molecular mechanisms by which disruption of SEs inhibits cancer stemness and invasion of HNSCC. Novel findings from our studies may lead to the development of novel strategies for the treatment of human HNSCC.

该应用程序的长期目标是了解超级增强子（se）如何控制细胞的生长